drug

Digital: Kiso Mind App

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Charite University, Berlin, Germany
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
NCT07395206—Recruiting

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Charite University, Berlin, Germany
company
trial
Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
NA
trial
indication
Schizophrenia
indication
Psychosis
indication
Schizophrenia
indication
Primary Psychotic Disorders
indication